Cerebrospinal Fluid (CSF) Management Market: Qualitative Analysis, Quantitative Analysis, Forecast up to 2030

SDKI Inc. published a new research report on "Cerebrospinal Fluid (CSF) Management Market-Global Forecast 2022". The report provides a complete assessment of the market and its growth prospects, along with new business opportunities in the industry. In addition, it includes market size and annual growth rate during the 2017-2022 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-109775

The global cerebrospinal fluid (CSF) management market is estimated to grow from US $ 1.26 billion in 2017 to US $ 1.56 billion by 2022, growing at a compound annual growth rate of 4.4%.

The high prevalence of hydrocephalus, the subsequent increase in the number of shunt procedures, and the increase in the elderly population are factors driving the growth of this market. Growing healthcare infrastructure in developing countries is also expected to provide market players with growth opportunities.

Market segment

Cerebrospinal fluid (CSF) management market by product (shunt (ventricular abdominal cavity, ventricular abdominal cavity, adjustable valve), external drainage system (EVD, lumbar drainage)), by end user (pediatric, adult, old) And divided by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Report sample URL
https://www.sdki.jp/sample-request-109775

Based on the product, the shunt segment is expected to grow at a maximum CAGR during the forecast period (2017-2022).

Based on the product, the market is divided into shunts and external drainage systems. The shunt segment is expected to grow at a maximum CAGR during the forecast period. This can be due to an increase in the number of shunt procedures performed worldwide, and an increase in the number of modified shunt surgeries performed due to shunt malfunctions and infections.

Based on end users, the pediatric segment is expected to be the fastest growing segment during the forecast period.

Based on end users, the global cerebrospinal fluid (CSF) management market is divided into pediatric, adult, and elderly end users. The pediatric segment is expected to grow at a maximum CAGR during the forecast period. This growth is due to the high prevalence of congenital hydrocephalus and the increased number of shunt procedures performed in the pediatric population.

Regional Overview

In addition, the report covers all regions of the world, divided into North America, Europe, Asia Pacific, Latin America, Middle East & Africa and more. The Asia Pacific region is expected to grow at a significant CAGR during the forecast period. The highest growth rates in the Asia-Pacific market can be attributed primarily to the high prevalence of congenital hydrocephalus in China, the growing elderly population in Japan, and increased medical tourism in India and some RoAPAC countries. There is sex.

For more detailed analysis, each region is further divided into countries:
Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, and other Asia Pacific)
North America (US and Canada)
Middle East and Africa (Israel, GCC [Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa)
Latin America (Brazil, Mexico, Argentina, and other Latin America)
Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe).

Details of the survey report
https://www.sdki.jp/reports/cerebrospinal-fluid-csf-management-market/109775

Key Players:

In the cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (USA), B.Braun (Germany), DePuy Synthes (USA), Spiegelberg GmbH & Co.KG ( Germany), SOPHYSA (France), Natus Medical (USA), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G.SURGIWEARLTD. (India), Wellong Instruments Co., Ltd. (Taiwan), etc. The study includes a detailed competitive analysis of these major companies in the cerebrospinal fluid (CSF) management market, corporate profiles, recent developments, and key market strategies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.